TuisCRSP • NASDAQ
add
Crispr Therapeutics AG
Vorige sluiting
$48,29
Dagwisseling
$48,40 - $49,24
Jaarwisseling
$37,55 - $91,10
Markkapitalisasie
4,17 mjd USD
Gemiddelde volume
1,03 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 517,00 k | -99,26% |
Bedryfskoste | 19,48 m | 2,36% |
Netto inkomste | -126,41 m | -62,60% |
Netto winsgrens | -24,45 k | -21 915,39% |
Wins per aandeel | -1,49 | -52,04% |
EBITDA | -146,42 m | -62,21% |
Effektiewe belastingkoers | -1,03% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,00 mjd | 13,21% |
Totale bates | 2,34 mjd | 6,50% |
Totale aanspreeklikheid | 358,90 m | -5,80% |
Totale ekwiteit | 1,98 mjd | — |
Uitstaande aandele | 85,17 m | — |
Prys om te bespreek | 2,07 | — |
Opbrengs op bates | -15,83% | — |
Opbrengs op kapitaal | -16,69% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -126,41 m | -62,60% |
Kontant van bedrywe | -95,58 m | 28,27% |
Kontant van beleggings | -126,90 m | -158,50% |
Kontant van finansiering | -466,00 k | -102,78% |
Netto kontantverandering | -222,95 m | -321,91% |
Beskikbare kontantvloei | -55,64 m | 52,07% |
Meer oor
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Gestig
2013
Hoofkwartier
Webwerf
Werknemers
407
